Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001493152-25-005072
Filing Date
2025-02-06
Accepted
2025-02-05 21:30:32
Documents
25

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 3040148
2 formdrs_001.jpg GRAPHIC 9487
3 formdrs_002.jpg GRAPHIC 64043
4 formdrs_003.jpg GRAPHIC 111402
5 chart_001.jpg GRAPHIC 58085
6 chart_002.jpg GRAPHIC 27227
7 formdrs_006.jpg GRAPHIC 14386
8 formdrs_008.jpg GRAPHIC 62524
9 formdrs_009.jpg GRAPHIC 63954
10 formdrs_010.jpg GRAPHIC 157425
11 formdrs_012.jpg GRAPHIC 5558
12 formdrs_028.jpg GRAPHIC 62598
13 formdrs_029.jpg GRAPHIC 67685
14 formdrs_030.jpg GRAPHIC 98000
15 formdrs_038.jpg GRAPHIC 68682
16 formdrs_032.jpg GRAPHIC 188695
17 formdrs_033.jpg GRAPHIC 167160
18 formdrs_034.jpg GRAPHIC 35591
19 formdrs_020.jpg GRAPHIC 169129
20 formdrs_035.jpg GRAPHIC 32406
21 formdrs_036.jpg GRAPHIC 29376
22 formdrs_037.jpg GRAPHIC 36999
23 chart_003.jpg GRAPHIC 182720
24 formdrs_025.jpg GRAPHIC 114252
25 formdrs_027.jpg GRAPHIC 10551
  Complete submission text file 0001493152-25-005072.txt   5574564
Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Filer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-07416 | Film No.: 25595173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)